v3.26.1
Segment Reporting - Schedule of Significant Expense Categories (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Schedule of Significant Expense Categories [Line Items]            
Total research and development $ 503,020   $ 146,901   $ 685,167 $ 316,605
Total general and administrative 3,285,481   489,325   3,988,926 861,071
Other Segment (Income) Expenses (16,493)   19,717   21,206 17,884
Net Loss 3,772,008 $ 923,291 655,943 $ 539,617 4,695,299 1,195,560
Personnel [Member]            
Schedule of Significant Expense Categories [Line Items]            
Total research and development 265,815   137,609   428,599 280,233
Total general and administrative 244,065   116,922   390,905 189,049
Clinical and preclinical activities [Member]            
Schedule of Significant Expense Categories [Line Items]            
Total research and development 230,875   5,662   246,608 29,112
Other [Member]            
Schedule of Significant Expense Categories [Line Items]            
Total research and development 6,330   3,630   9,960 7,260
Professional services [Member]            
Schedule of Significant Expense Categories [Line Items]            
Total general and administrative 2,819,556   268,640   3,247,071 470,128
Corporate expenses [Member]            
Schedule of Significant Expense Categories [Line Items]            
Total general and administrative 182,260   66,262   274,333 126,794
Facility costs [Member]            
Schedule of Significant Expense Categories [Line Items]            
Total general and administrative $ 39,600   $ 37,501   $ 76,617 $ 75,100